Current future status Etoposide antineoplastic agent demonstrated efficacy broad spectrum human malignancies testicular germ cell lung cancers synergistic agents part combination chemotherapy etoposide so-called standard therapies testicular cancer small cell lung cancer activity tumors lymphoma leukemia solid tumors identifies important chemotherapeutic agent Cellular animal models cell kill tumor response depend dose time exposure Recent clinical studies dose schedule etoposide important effects clinical response drug Further research use etoposide part initial therapy several cancers doses prolonged schedules agent potential 